RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer
about
Discovery of estrogen receptor alpha target genes and response elements in breast tumor cellsIdentification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6KActivator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated regionAdult rat bones maintain distinct regionalized expression of markers associated with their developmentMenin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23The Ras-related protein AGS1/RASD1 suppresses cell growthRLP, a novel Ras-like protein, is an immediate-early transforming growth factor-beta (TGF-beta) target gene that negatively regulates transcriptional activity induced by TGF-betaInhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.Whole-genome cartography of estrogen receptor alpha binding sites.The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia.Rasl11b knock down in zebrafish suppresses one-eyed-pinhead mutant phenotype.Mining mammalian transcript data for functional long non-coding RNAs.MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.Targeting protein prenylation for cancer therapyHuman RAS superfamily proteins and related GTPases.Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant populationERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosisProstasomal DNA characterization and transfer into human sperm.ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.Dioxin increases the interaction between aryl hydrocarbon receptor and estrogen receptor alpha at human promoters.Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy.Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.Evaluating the evidence for targeting FOXO3a in breast cancer: a systematic review.Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct populationFOXA1 represses the molecular phenotype of basal breast cancer cellsPrognostic value of a 92-probe signature in breast cancer.CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signallingIdentification of genes underlying different methylation profiles in refractory anemia with excess blast and refractory cytopenia with multilineage dysplasia in myelodysplastic syndrome.A candidate molecular signature associated with tamoxifen failure in primary breast cancerMethylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferasesRegulation of gene expression by estrogen and testosterone in the proximal mouse reproductive tract.Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Identification of differentially expressed genes and their upstream regulators in colorectal cancer.Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.Computational method for discovery of estrogen responsive genes.
P2860
Q21184176-BC53D1D9-8D36-4A3B-898E-B6E014204BD5Q24309411-66C6A610-773E-43F3-A63E-48831DFCC79BQ24530625-54F88800-B209-458B-B765-D61272647824Q24810319-0F771C61-F886-4EAC-8200-90E9634DC922Q28216208-434B96B5-B9D5-41AA-B70D-A078AC78F3CDQ28265751-36DFAA64-4DDD-40E1-9AE7-89F3AB7A9D29Q28508588-1B921D8B-B638-4E31-867D-EB3DDC80B377Q31115129-30ED6C6B-C9A7-4929-ABA3-CB35E247CB06Q33248484-6926C589-9DE5-481C-9445-3295DA85F2EBQ33286418-444FAA3F-0E37-445A-B0DC-37DA52D205A3Q33302690-FCBDD8A7-4C39-4B50-9FA1-3FE03938D0C8Q33314901-BEBEB2D5-89E9-4452-A47F-0E94131FB5F9Q33567626-F4DF884B-A7AB-4362-B0DE-DBF06AD3F5D1Q33618363-0AD5DA9D-3322-4F9E-80C4-706092C5D1BFQ33679239-2B1A9376-F939-4A8E-9FB2-5F2B3AFA4B8BQ33689727-312BE665-E8DE-48A7-B172-CE74BF4D0E99Q33739680-D7B523BF-A0DE-4E80-AC50-2E640241C16CQ33850829-673D7BFB-96CE-4760-B2A4-9617E2ED4B3DQ33915044-AE52D05E-F1FB-4BB2-BB2D-8EDA0A3FB93CQ33977461-8E573FE9-0C19-418A-A484-D708AEE31D22Q34189593-D5B059A8-C51D-4E96-9205-15EC7BE1CFDDQ34200697-BCF2C3DB-914A-4D5A-A87E-1634B5E72177Q34393481-C35B975C-0035-40BB-8F53-6097D24EEA23Q34984191-C68DB5B9-ED0C-40D7-B028-C7E95082C004Q35013493-37A9F6AC-44CD-47D9-9778-12390317424DQ35077393-B3954DE8-AAD6-4109-AFBA-7627FF0D2303Q36006125-A150C624-97D7-493B-8D71-61448265DF71Q36020557-8B62D1D4-846D-4047-9F65-1B44BEF7D3D8Q36021090-FD7E6ADD-85BB-428A-BD77-78D12C0E119DQ36075168-7FBB7C29-2135-4352-BC92-D593D27D3E73Q36297655-CED13498-4B9A-42C8-BA3D-D897F86A9D9EQ37038692-CC172BC4-26C8-4664-B168-DC6B6A4BFB3CQ37121671-9B62F300-BD3B-474D-BC4F-FFC45781E2D0Q37292300-C2C432E3-A174-4486-A2E9-5EA77BA8A68AQ37369739-50864645-3833-4FC7-9B6C-6D2602C1494FQ37515474-476F0235-76D5-4458-A5C0-300C1C829D90Q38563527-6DD0491B-5482-4C69-922F-532F18B80EFAQ38837129-BB087507-CC4E-43E3-A656-A5CDFC785B8CQ38900933-88BC912A-B371-4FDE-B2F1-E9E631C3B40DQ40636982-D4E4C799-AFB1-45FD-B484-7E69CBCF2754
P2860
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@ast
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en-gb
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@nl
type
label
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@ast
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en-gb
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@nl
prefLabel
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@ast
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en-gb
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@nl
P2093
P2860
P50
P3181
P356
P1476
RERG is a novel ras-related, e ...... hibitory gene in breast cancer
@en
P2093
B S Finlin
D A Andres
G A Murphy
P2860
P304
P3181
P356
10.1074/JBC.M105888200
P407
P577
2001-11-09T00:00:00Z